(19)
(11) EP 3 921 647 A1

(12)

(43) Date of publication:
15.12.2021 Bulletin 2021/50

(21) Application number: 20702690.7

(22) Date of filing: 07.02.2020
(51) International Patent Classification (IPC): 
G01N 33/574(2006.01)
 A61K 47/69(2017.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/574; C07F 1/12; A61P 35/00; A61K 33/242; G01N 2800/52; A61K 47/6951
(86) International application number:
PCT/EP2020/053203
(87) International publication number:
WO 2020/161337 (13.08.2020 Gazette 2020/33)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 07.02.2019 EP 19155958

(71) Applicant: Deutsches Krebsforschungszentrum - Stiftung des öffentlichen Rechts / Universität Heidelberg
69120 Heidelberg (DE)

(72) Inventors:
  • GUNKEL, Nikolas
    69121 Heidelberg (DE)
  • AMTMANN, Eberhard
    69121 Heidelberg (DE)
  • MORGEN, Michael
    56812 Valwig (DE)
  • MILLER, Aubry
    69126 Heidelberg (DE)

(74) Representative: Kuttenkeuler, David 
Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22
80336 München
80336 München (DE)

   


(54) IMPROVED DITHIOCARMABATE BASED COMPOUNDS, THERAPIES AND DIAGNOSTICS